| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |